Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Atherosclerosis

• Publication date

  2013-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.atherosclerosis.2013.08.006PMID 24075764
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ezetimibe Inhibits Hepatic Niemann-Pick C1-Like 1 to Facilitate Macrophage Reverse Cholesterol Transport in Mice

  2013cited by this paper
• In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1[S]

  2013cited by this paper
• Measurement of Reverse Cholesterol Transport Pathways in Humans: In Vivo Rates of Free Cholesterol Efflux, Esterification, and Excretion

  2012influential reference
• Intestinal sterol transporters and cholesterol absorption inhibition

  2011cited by this paper
• The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

  2011cited by this paper
• Effects of ezetimibe on atherosclerosis in preclinical models.

  2011cited by this paper
• Quantifying cholesterol synthesis in vivo using 2H2O: enabling back-to-back studies in the same subject

  2011cited by this paper
• An update on the IMProved reduction of outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) design.

  2010cited by this paper
• Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

  2010cited by this paper
• Ezetimibe stimulates faecal neutral sterol excretion depending on abcg8 function in mice

  2010cited by this paper
• Transintestinal cholesterol efflux.

  2010cited by this paper
• Both the Peroxisome Proliferator‐Activated Receptor δ Agonist, GW0742, and Ezetimibe Promote Reverse Cholesterol Transport in Mice by Reducing Intestinal Reabsorption of HDL‐Derived Cholesterol

  2009influential reference
• Extended-release niacin or ezetimibe and carotid intima-media thickness.

  2009cited by this paper
• Model system for the analysis of cell surface expression of human ABCA1

  2009cited by this paper
• Ezetimibe reduces plaque inflammation in a rabbit model of atherosclerosis and inhibits monocyte migration in addition to its lipid‐lowering effect

  2009cited by this paper
• Changes in cholesterol absorption and cholesterol synthesis caused by ezetimibe and/or simvastatin in men

  2009influential reference
• patient-oriented and epidemiological research Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia

  2009cited by this paper
• The role of Niemann-Pick C1 - Like 1 (NPC1L1) in intestinal sterol absorption.

  2008influential reference
• Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches.

  2008cited by this paper
• Cholesterol Absorption From the Intestine Is a Major Determinant of Reverse Cholesterol Transport From Peripheral Tissue Macrophages

  2008influential reference
• Ezetimibe: cholesterol lowering and beyond

  2008cited by this paper
• Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe–statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia

  2008cited by this paper
• Origins of intestinal ABCA1-mediated HDL-cholesterol** This work was supported by National Institutes of Health Grant DK-067132. Published, JLR Papers in Press, August 18, 2008.

  2008cited by this paper
• Ezetimibe interferes with cholesterol trafficking from the plasma membrane to the endoplasmic reticulum in CaCo-2 cells Published, JLR Papers in Press, May 1, 2007.

  2007cited by this paper
• Class B type I scavenger receptor is responsible for the high affinity cholesterol binding activity of intestinal brush border membrane vesicles.

  2007cited by this paper
• Effect of Ezetimibe on the In Vivo Kinetics of ApoB-48 and ApoB-100 in Men With Primary Hypercholesterolemia

  2006cited by this paper
• Emerging roles of the intestine in control of cholesterol metabolism.

  2006cited by this paper
• REVIEW: Efficacy and mechanisms of action of statins in the treatment of diabetic dyslipidemia.

  2006cited by this paper
• Intestinal cholesterol absorption inhibitor ezetimibe added to cholestyramine for sitosterolemia and xanthomatosis.

  2006cited by this paper
• Inhibition of cholesterol absorption by the combination of dietary plant sterols and ezetimibe: effects on plasma lipid levels.

  2005cited by this paper
• Carotenoid transport is decreased and expression of the lipid transporters SR-BI, NPC1L1, and ABCA1 is downregulated in Caco-2 cells treated with ezetimibe.

  2005cited by this paper
• Delineation of molecular changes in intrahepatic cholesterol metabolism resulting from diminished cholesterol absorption Published, JLR Papers in Press, January 16, 2005. DOI 10.1194/jlr.M400475-JLR200

  2005cited by this paper
• Ezetimibe Effectively Reduces Plasma Plant Sterols in Patients With Sitosterolemia

  2004cited by this paper
• Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans Published, JLR Papers in Press, May 16, 2004. DOI 10.1194/jlr.M300511-JLR200

  2004cited by this paper
• Inhibition of Intestinal Cholesterol Absorption by Ezetimibe in Humans

  2002cited by this paper
• The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys.

  2001cited by this paper
• Theoretical considerations of what regulates low-density-lipoprotein and high-density-lipoprotein cholesterol.

  1997cited by this paper
• Measurement of fractional lipid synthesis using deuterated water (2H2O) and mass isotopomer analysis.

  1994cited by this paper
• Cholesterol kinetics in subjects with bile fistula. Positive relationship between size of the bile acid precursor pool and bile acid synthetic rate.

  1993cited by this paper

• Hypolipidemic and anti-atherosclerogenic effect of Glycyrrhiza glabra root extract in high fat diet induced hypercholesterolemic rats

  2025cites this paper
• High cholesterol absorption efficiency increases the risk of the nonfatal and fatal atherosclerotic events

  2025cites this paper
• High cholesterol absorption efficiency interferes with bile acid metabolism and cholesterol elimination from the body.

  2025cites this paper
• Cholesin and GPR146 in Modulating Cholesterol Biosynthesis

  2024cites this paper
• Heart-healthy diets including phytostanol ester consumption to reduce the risk of atherosclerotic cardiovascular diseases. A clinical review

  2024influential citation
• New Insights into the Importance of Dietary Cholesterol in Preventing Cardiovascular Disease.

  2024cites this paper
• A gut-derived hormone regulates cholesterol metabolism.

  2024cites this paper
• High cholesterol absorption: A risk factor of atherosclerotic cardiovascular diseases?

  2023cites this paper
• Advances in Treatment of Dyslipidemia

  2023cites this paper
• Simultaneous Determination of Bempedoic Acid and Ezetimibe in Rat Plasma Using HPLC–PDA and Its Applications to a Pharmacokinetic Study

  2022cites this paper
• Therapeutic Lipidology

  2021influential citation
• Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism

  2021cites this paper
• HDL AND REVERSE CHOLESTEROL TRANSPORT IN HUMANS AND ANIMALS: LESSONS FROM PRE-CLINICAL MODELS AND CLINICAL STUDIES.

  2021cites this paper
• REGULATION OF THE EXPRESSION OF CHOLESTEROL TRANSPORTERS BY LIPID-LOWERING DRUGS EZETIMIBE AND PEMAFIBRATE IN RAT LIVER AND INTESTINE.

  2021cites this paper
• Recent Molecular Mechanisms and Beneficial Effects of Phytochemicals and Plant-Based Whole Foods in Reducing LDL-C and Preventing Cardiovascular Disease

  2021cites this paper
• Antihyperlipidemic Effects of Methanol Extract of Seeds of Citrullus lanatus in Hyperlipidemic Rats

  2021cites this paper
• Lipid optimisation in lower extremity peripheral arterial disease.

  2021cites this paper
• Serum metabolic signatures of subclinical atherosclerosis in patients with type 2 diabetes mellitus: a preliminary study

  2021cites this paper
• Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism

  2020cites this paper
• Intestinally Active Therapies for Hypercholesterolemia: Ezetimibe, Bile Acid Resins, and Plant Sterols

  2020cites this paper
• Diosgenin alleviates hypercholesterolemia via SRB1/CES-1/CYP7A1/FXR pathway in high-fat diet-fed rats.

  2020cites this paper
• Ezetimibe promotes CYP7A1 and modulates PPARs as a compensatory mechanism in LDL receptor-deficient hamsters

  2020cites this paper
• Combined Effect of Diosgenin Along with Ezetimibe or Atorvastatin on the Fate of Labelled Bile Acid and Cholesterol in Hypercholesterolemic Rats

  2019cites this paper
• Ezetimibe Monotherapy Reduces Serum Levels of Platelet-Activating Factor Acetylhydrolase in Patients With Dyslipidemia

  2019cites this paper
• Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteins.

  2018cites this paper
• Biochemical Activity and Hypoglycemic Effects of Rumex obtusifolius L. Seeds Used in Armenian Traditional Medicine

  2018cites this paper
• Cholesterol metabolism in humans: a review of methods and comparison of results

  2018cites this paper
• Blood-based novel biomarkers for nonalcoholic steatohepatitis.

  2018cites this paper
• A nutraceutical formulation based on Annurca apple polyphenolic extract is effective on intestinal cholesterol absorption: A randomised, placebo-controlled, crossover study

  2018cites this paper
• Antiatherogenic potential of ezetimibe in sitosterolemia: Beyond plant sterols lowering.

  2017cites this paper
• Development and validation of simple and rapid LC-MS / MS method for ezetimibe in human plasma and its application to bioequivalence study

  2017cites this paper
• Endogenous Cholesterol Excretion Is Negatively Associated With Carotid Intima–Media Thickness in Humans

  2017cites this paper
• Ezetimibe Increases Endogenous Cholesterol Excretion in Humans

  2017cites this paper
• Hypolipidemic, antioxidant and anti-atherosclerogenic effect of aqueous extract leaves of Cassia. occidentalis Linn (Caesalpiniaceae) in diet-induced hypercholesterolemic rats

  2017cites this paper
• The Interpretation of Cholesterol Balance Derived Synthesis Data and Surrogate Noncholesterol Plasma Markers for Cholesterol Synthesis under Lipid Lowering Therapies

  2017cites this paper
• Effect of two lipid-lowering strategies on high-density lipoprotein function and some HDL-related proteins: a randomized clinical trial

  2017cites this paper
• Niemann-Pick C1-Like 1 (NPC1L1) Inhibition and Cardiovascular Diseases.

  2016cites this paper
• Ezetimibe Promotes Brush Border Membrane-to-Lumen Cholesterol Efflux in the Small Intestine

  2016cites this paper
• Farnesoid X receptor activation increases reverse cholesterol transport by modulating bile acid composition and cholesterol absorption in mice

  2016influential citation
• Modulating cholesterol efflux capacity to improve cardiovascular disease

  2016cites this paper
• Plasma Cholesterol-Lowering Activity of Lard Functionalized with Mushroom Extracts Is Independent of Niemann-Pick C1-like 1 Protein and ABC Sterol Transporter Gene Expression in Hypercholesterolemic Mice.

  2016cites this paper
• Cholesterol is a significant risk factor for non-alcoholic steatohepatitis

  2015cites this paper
• Physiological Modulation of the Reverse Cholesterol Transport Pathway in Vivo Reija Silvennoinen

  2015cites this paper
• A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretion.

  2015cites this paper
• Hypolipidemic, antioxidant and anti-atherosclerogenic effects of aqueous extract of Zanthoxylum heitzii stem bark in diet-induced hypercholesterolemic rats.

  2015cites this paper
• Simultaneous determination of ezetimibe and its glucuronide metabolite in human plasma by solid phase extraction and liquid chromatography-tandem mass spectrometry.

  2015cites this paper
• Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA[S]

  2015cites this paper
• Acute Intake of Plant Stanol Esters Induces Changes in Lipid and Lipoprotein Metabolism-Related Gene Expression in the Liver and Intestines of Mice

  2015cites this paper
• PHYSIOLOGICAL MODULATION OF THE REVERSE CHOLESTEROL TRANSPORT PATHWAY IN VIVO

  2015cites this paper
• Plant stanol esters: focus on intestinal lipoprotein metabolism

  2014influential citation
• Recent approaches of lipid-based delivery system for lymphatic targeting via oral route

  2014cites this paper
• Clinical utility of serum markers of cholesterol absorption and synthesis

  2014cites this paper
• Reverse cholesterol transport fluxes

  2014cites this paper